gabexate has been researched along with Acute Brain Injuries in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Excerpt | Relevance | Reference |
---|---|---|
"The occurrence of disseminated intravascular coagulation (DIC) is not rare in neurosurgical patients." | 1.28 | [Diagnosis and treatment of disseminated intravascular coagulation associated with neurosurgical diseases; a proposal of a new scoring system for DIC]. ( Fujii, Y; Kameyama, S; Koike, T; Takahashi, H; Tanaka, R, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kameyama, S | 1 |
Fujii, Y | 1 |
Koike, T | 1 |
Tanaka, R | 1 |
Takahashi, H | 1 |
1 other study available for gabexate and Acute Brain Injuries
Article | Year |
---|---|
[Diagnosis and treatment of disseminated intravascular coagulation associated with neurosurgical diseases; a proposal of a new scoring system for DIC].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Diseases; Brain Injuries; Cerebrovascular Disorder | 1992 |